Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 1 , Pages 19-27 , February 2010

Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer

  • Spyros Papaioannou, MD, MRCOG (Honorary Senior Lecturer, University of Birmingham, Consultant Obstetrician and Gynaecologist)

      Affiliations

    • Heart of England NHS Foundation Trust, Heartlands Hospital, University of Birmingham, Birmingham B9 5SS, UK
    • Corresponding Author InformationCorresponding author. Fax: +44 121 4243130.
    • ,
  • John Tzafettas, MD, PhD, FRCOG (Professor of Obstetrics and Gynaecology)

      Affiliations

    • 2nd Department of Obstetrics and Gynecology, Aristoteleion University of Thessaloniki, Hippokration Gerneral Hospital, 49 Konstantinoupoleos Street, 54642 Thessaloniki, Greece

References 

  1. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem. 2008 Feb;114(1):71–83
  2. Polson DW, Adams J, Wadsworth J, et al. Polycystic ovaries – a common finding in normal women. Lancet. 1988 Apr 16;1(8590):870–872
  3. Farquhar CM, Birdsall M, Manning P, et al. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol. 1994 Feb;34(1):67–72
  4. Wijeyaratne CN, Balen AH, Barth JH, et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clin Endocrinol (Oxf). 2002 Sep;57(3):343–350
  5. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 Jan;19(1):41–47
  6. Speert H. Carcinoma of the endometrium in young women. Surg Gynecol Obstet. 1949 Mar;88(3):332–336
  7. Stein IFLML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181–191
  8. Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol. 1978 Jan;51(1):97–100
  9. Chamlian DL, Taylor HB. Endometrial hyperplasia in young women. Obstet Gynecol. 1970 Nov;36(5):659–666
  10. Kurabayashi T, Kase H, Suzuki M, et al. Endometrial abnormalities in infertile women. J Reprod Med. 2003 Jun;48(6):455–459
  11. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol. 1983 Apr;61(4):403–407
  12. Escobedo LG, Lee NC, Peterson HB, et al. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol. 1991 Jan;77(1):124–128
  13. Long-term consequences of polycystic ovary syndrome. London: RCOG; 2003;Ref Type: Pamphlet
  14. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update. 2001 Nov;7(6):522–525
  15. Fechner RE, Kaufman RH. Endometrial adenocarcinoma in Stein–Leventhal syndrome. Cancer. 1974 Aug;34(2):444–452
  16. Muechler EK, Bonfiglio T, Choate J, et al. Pregnancy induced with menotropins in a woman with polycystic ovaries, endometrial hyperplasia, and adenocarcinoma. Fertil Steril. 1986 Nov;46(5):973–975
  17. Yarali H, Bozdag G, Aksu T, et al. A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil Steril. 2004 Jan;81(1):214–216
  18. Anderson KE, Sellers TA, Chen PL, et al. Association of Stein–Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer. 1997 Feb 1;79(3):494–499
  19. Wild S, Pierpoint T, Jacobs H, et al. Long-term consequences of polycystic ovary syndrome: results of a 31-year follow-up study. Hum Fertil (Camb). 2000;3(2):101–105
  20. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol. 1991 Oct 15;134(8):818–824
  21. Barnes RB. Diagnosis and therapy of hyperandrogenism. Baillieres Clin Obstet Gynaecol. 1997 Jun;11(2):369–396
  22. Hackenberg R, Hannig K, Beck S, et al. Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells. Eur J Cancer. 1996 Apr;32A(4):696–701
  23. Ito K, Suzuki T, Akahira J, et al. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders. Int J Cancer. 2002 Jun 10;99(5):652–657
  24. Jongen VH, Sluijmer AV, Heineman MJ. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. Maturitas. 2002 Oct 25;43(2):77–85
  25. Legro RS, Kunselman AR, Miller SA, et al. Role of androgens in the growth of endometrial carcinoma: an in vivo animal model. Am J Obstet Gynecol. 2001 Feb;184(3):303–308
  26. Secreto G, Toniolo P, Berrino F, et al. Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res. 1991 May 15;51(10):2572–2576
  27. Secreto G, Toniolo P, Pisani P, et al. Androgens and breast cancer in premenopausal women. Cancer Res. 1989 Jan 15;49(2):471–476
  28. Gordon GB, Bush TL, Helzlsouer KJ, et al. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res. 1990 Jul 1;50(13):3859–3862
  29. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973 Feb;36(2):207–214
  30. Kaye SA, Folsom AR, Soler JT, et al. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol. 1991 Mar;20(1):151–156
  31. Sellers TA, Gapstur SM, Potter JD, et al. Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer. Am J Epidemiol. 1993 Nov 15;138(10):799–803
  32. Bryan RM, Mercer RJ, Bennett RC, et al. Androgen receptors in breast cancer. Cancer. 1984 Dec 1;54(11):2436–2440
  33. Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update. 1996 Jan;2(1):63–75
  34. Weiderpass E, Persson I, Adami HO, et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control. 2000 Feb;11(2):185–192
  35. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):276–280
  36. Mulholland HG, Murray LJ, Cardwell CR, et al. Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer. 2008 Aug 5;99(3):434–441
  37. Nagamani M, Hannigan EV, Dinh TV, et al. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J Clin Endocrinol Metab. 1988 Jul;67(1):144–148
  38. Soliman PT, Wu D, Tortolero-Luna G, et al. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer. 2006 Jun 1;106(11):2376–2381
  39. Vona-Davis L, Howard-McNatt M, Rose DP. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev. 2007 Sep;8(5):395–408
  40. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007 Sep;86(3):s823–s835
  41. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002 Jan 1;20(1):42–51
  42. Goodwin PJ, Ennis M, Bahl M, et al. High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome. Breast Cancer Res Treat. 2008 Apr 25;
  43. Stall BAaSG . New hormone related markers of high risk to breast cancer. Ann Oncol. 1992;3:435–438
  44. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006 Jun;13(2):279–292
  45. Elwood JM, Cole P, Rothman KJ, et al. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977 Oct;59(4):1055–1060
  46. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol. 1974 Aug;2(2–3):122–129
  47. Dahlgren E, Friberg LG, Johansson S, et al. Endometrial carcinoma; ovarian dysfunction–a risk factor in young women. Eur J Obstet Gynecol Reprod Biol. 1991 Sep 13;41(2):143–150
  48. Dahlgren E, Johansson S, Oden A, et al. A model for prediction of endometrial cancer. Acta Obstet Gynecol Scand. 1989;68(6):507–510
  49. Henderson BE, Casagrande JT, Pike MC, et al. The epidemiology of endometrial cancer in young women. Br J Cancer. 1983 Jun;47(6):749–756
  50. Horn LC, Dietel M, Einenkel J. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis. Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):4–12
  51. Polin SA, Ascher SM. The effect of tamoxifen on the genital tract. Cancer Imaging. 2008;8:135–145
  52. Vasen HF. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer). Aliment Pharmacol Ther. 2007 Dec;26(Suppl. 2):113–126
  53. Clavel-Chapelon F. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer. 2002 Mar 4;86(5):723–727
  54. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15(1):36–47
  55. Ewertz M, Duffy SW, Adami HO, et al. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer. 1990 Oct 15;46(4):597–603
  56. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002 Jul 20;360(9328):187–195
  57. Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002 Apr 17;94(8):606–616
  58. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000 Sep 15;152(6):514–527
  59. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003 Aug 9;362(9382):419–427
  60. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998 Mar;62(3):676–689

PII: S1521-6934(09)00023-6

doi: 10.1016/j.bpobgyn.2008.11.010

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 1 , Pages 19-27 , February 2010

Article Tools